Inogen Inc (INGN) Dividend History

Inogen Inc (INGN) is a medical technology company that specializes in designing and manufacturing portable oxygen concentrators for people with respiratory conditions. Founded in 2001, Inogen's innovative devices enable patients to maintain greater mobility and independence while receiving oxygen therapy. The company's products are used primarily in the home and during travel, offering a portable alternative to traditional oxygen tanks.

859 Ward Drive, Goleta, CA, 93111
Phone: 805-562-0500
Website: https://www.inogen.com

Dividend History

Inogen Inc currently does not pay dividends

Company News

Tosyalı lance l'un des plus grands projets de centrale solaire en autoconsommation au monde

Tosyalı, a major global green steel producer, is expanding its renewable energy efforts by signing an agreement with GE Vernova and Inogen for the first 120 MWp of its 1.2 GW solar self-consumption project in Türkiye. The project will use locally produced Tosyalı V-Solar panels and aims to meet around 50% of Tosyalı's energy needs through solar power.

GlobeNewswire Inc.

Featured Companies: GEV
Tosyalı Launches one of the World’s Largest Self-Consumption Solar Power Plant Projects

Tosyalı, a leading global green steel producer, is investing in a 1.2 GW self-consumption solar power plant project in Turkey. The project will utilize Tosyalı's locally produced solar panels and is being developed in partnership with GE Vernova and Inogen. The project aims to meet around 50% of Tosyalı's energy needs from solar power, strengthening its position as a green steel producer.

GlobeNewswire Inc.

Featured Companies: GEV
Here's Why You Should Add Inogen Stock to Your Portfolio Now

Inogen is well-positioned for growth in the portable oxygen concentrator (POC) market, with a strong product portfolio and solid Q2 results. However, it faces stiff competition and forex volatility. The company's stock has outperformed the industry and the S&P 500 year-to-date.

Benzinga

Featured Companies: AXGN SIBN
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now - Zacks Investment Research

Inogen, Inc. is well-poised for growth in the portable oxygen concentrator (POC) market, driven by a strong product portfolio and solid Q1 2024 performance. However, the company faces stiff competition and forex volatility, which are major downsides.

Zacks Investment Research

Featured Companies: DXCM ISRG UHS
Charles River (CRL) Advances in T-Cell Therapy With New Alliance

Charles River (CRL) and Captain T Cell announced an agreement on plasmid DNA and retrovirus vector production program for the treatment of patients having solid tumor.

Zacks Investment Research

Featured Companies: CRL MEDP RMD

Dividend data last updated 06/07/2025 03:16:14 UTC